Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Priya Nigam

Traders See Bumpy Road Ahead For Gilead Sciences

Gilead Sciences, Inc. (NASDAQ:GILD) climbed on Wednesday, even as the S&P 500 ended the day with losses.

On CNBC's "Options Action," Tony Zhang said that Gilead Sciences traded nearly 2.5 times its average daily volume on Thursday.

Check out other stocks making big moves in the premarket.

There was a buyer of more than 11,000 of the September 62.5 calls at $2.43 per contract on average, Zhang mentioned. The trader “clearly sees very limited upside for Gilead,” he added. The seller expects shares of Gilead Sciences to remain below $62.50 by September expiration.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.